EP3809137A1
|
|
Methods and reagents for diagnosis of sars-cov-2 infection
|
WO2021048263A1
|
|
Improved detection of nmda receptor autoantibodies
|
US2021063393A1
|
|
Detection of an autoantibody
|
WO2021023836A1
|
|
An improved autoantibody detection assay
|
WO2021023816A1
|
|
A method and reagents for the diagnosis of mn
|
US2021003591A1
|
|
Novel assay for the diagnosis of nematode infections
|
KR20200146018A
|
|
A method and products for the diagnosis of a seafood allergy
|
EP3734286A1
|
|
A method for determining the efficacy of a sars-cov-2 vaccine
|
US2020341005A1
|
|
Carrier and method for detecting an analyte in dried blood spots
|
EP3715847A1
|
|
A method and reagents for the diagnosis of sars-cov-2
|
AU2020200382A1
|
|
Serological detection of Plasmodium antibodies
|
EP3667322A1
|
|
Serological detection of plasmodium antibodies
|
US2020191785A1
|
|
Method for Diagnosing Autoimmune Gastritis
|
SG10201908826UA
|
|
Diagnosis of blistering autoimmune diseases
|
EP3629021A1
|
|
Diagnosis of a neuroautoimmune disease
|
EP3767587A1
|
|
Detection of presence of different antinuclear antibody fluorescence pattern types and device for same
|
EP3753634A1
|
|
Sample carrier for receiving dried blood components and method for obtaining a membrane element with dried blood components
|
EP3712618A1
|
|
Method for detecting a binding of antibodies of a patient sample to double-stranded dna using crithidia luciliae cells and fluorescence microscopy
|
EP3755709A1
|
|
Assay for the diagnosis of viral infections
|
EP3699572A1
|
|
Incubation device made from a composite material and method for dyeing a sample
|